LBLouise Bloch

Louise Bloch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Louise Bloch has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MRI-based Radiomics and volumetrics for predicting the onset of Alzheimer’s Disease with explainable machine learning

    by Louise Bloch, Katarzyna Borys, Felix Nensa, Christoph M. Friedrich


  • Open Access

    Evaluating Compliance with Visualization Guidelines in Diagrams for Scientific Publications Using Large Vision Language Models

    by Johannes Rückert, Louise Bloch, Christoph M. Friedrich

    Diagrams are widely used to visualize data in publications. The research field of data visualization deals with defining principles and guidelines for the creation and use of these diagrams, which are often not known or adhered to by researchers, leading to misinformation caused by providing inaccurate or incomplete information. In this work, large Vision Language Models (VLMs) are used to analyze diagrams in order to identify potential problems in regards to selected data visualization principles and guidelines. To determine the suitability of VLMs for these tasks, five open source VLMs and five prompting strategies are compared using a set of questions derived from selected data visualization guidelines. The results show that the employed VLMs work well to accurately analyze diagram types (F1-score 82.49 %), 3D effects (F1-score 98.55 %), axes labels (F1-score 76.74 %), lines (RMSE 1.16), colors (RMSE 1.60) and legends (F1-score 96.64 %, RMSE 0.70), while they cannot reliably provide feedback about the image quality (F1-score 0.74 %) and tick marks/labels (F1-score 46.13 %). Among the employed VLMs, Qwen2.5VL performs best, and the summarizing prompting strategy performs best for most of the experimental questions. It is shown that VLMs can be used to automatically identify a number of potential issues in diagrams, such as missing axes labels, missing legends, and unnecessary 3D effects. The approach laid out in this work can be extended for further aspects of data visualization.

  • Top Cited Papers
    Open Access

    ROCOv2: Radiology Objects in COntext Version 2, an Updated Multimodal Image Dataset

    by Johannes Rückert, Louise Bloch, Raphael Brüngel, Ahmad Idrissi-Yaghir, Henning Schäfer, Cynthia S. Schmidt, Sven Koitka, Obioma Pelka, Asma Ben Abacha, Alba G. Seco de Herrera, et al.

    Automated medical image analysis systems often require large amounts of training data with high quality labels, which are difficult and time consuming to generate. This paper introduces Radiology Object in COntext version 2 (ROCOv2), a multimodal dataset consisting of radiological images and associated medical concepts and captions extracted from the PMC Open Access subset. It is an updated version of the ROCO dataset published in 2018, and adds 35,705 new images added to PMC since 2018. It further provides manually curated concepts for imaging modalities with additional anatomical and directional concepts for X-rays. The dataset consists of 79,789 images and has been used, with minor modifications, in the concept detection and caption prediction tasks of ImageCLEFmedical Caption 2023. The dataset is suitable for training image annotation models based on image-caption pairs, or for multi-label image classification using Unified Medical Language System (UMLS) concepts provided with each image. In addition, it can serve for pre-training of medical domain models, and evaluation of deep learning models for multi-task learning.


  • Open Access

    Machine Learning Workflow to Explain Black-box Models for Early Alzheimer's Disease Classification Evaluated for Multiple Datasets

    by Louise Bloch, Christoph M. Friedrich

    Purpose: Hard-to-interpret Black-box Machine Learning (ML) were often used for early Alzheimer's Disease (AD) detection. Methods: To interpret eXtreme Gradient Boosting (XGBoost), Random Forest (RF), and Support Vector Machine (SVM) black-box models a workflow based on Shapley values was developed. All models were trained on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset and evaluated for an independent ADNI test set, as well as the external Australian Imaging and Lifestyle flagship study of Ageing (AIBL), and Open Access Series of Imaging Studies (OASIS) datasets. Shapley values were compared to intuitively interpretable Decision Trees (DTs), and Logistic Regression (LR), as well as natural and permutation feature importances. To avoid the reduction of the explanation validity caused by correlated features, forward selection and aspect consolidation were implemented. Results: Some black-box models outperformed DTs and LR. The forward-selected features correspond to brain areas previously associated with AD. Shapley values identified biologically plausible associations with moderate to strong correlations with feature importances. The most important RF features to predict AD conversion were the volume of the amygdalae, and a cognitive test score. Good cognitive test performances and large brain volumes decreased the AD risk. The models trained using cognitive test scores significantly outperformed brain volumetric models ($p<0.05$). Cognitive Normal (CN) vs. AD models were successfully transferred to external datasets. Conclusion: In comparison to previous work, improved performances for ADNI and AIBL were achieved for CN vs. Mild Cognitive Impairment (MCI) classification using brain volumes. The Shapley values and the feature importances showed moderate to strong correlations.

  • Open Access

    Machine Learning Workflow to Explain Black-Box Models for Early Alzheimer’s Disease Classification Evaluated for Multiple Datasets

    by Louise Bloch, Christoph M. Friedrich, For The Alzheimer’s Disease Neuroimaging Initiative

    Hard-to-interpret black-box Machine Learning (ML) was often used for early Alzheimer’s Disease (AD) detection. To interpret eXtreme Gradient Boosting (XGBoost), Random Forest (RF), and Support Vector Machine (SVM) black-box models, a workflow based on Shapley values was developed. All models were trained on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset and evaluated for an independent ADNI test set, as well as the external Australian Imaging and Lifestyle flagship study of Ageing (AIBL), and Open Access Series of Imaging Studies (OASIS) datasets. Shapley values were compared to intuitively interpretable Decision Trees (DTs), and Logistic Regression (LR), as well as natural and permutation feature importances. To avoid the reduction of the explanation validity caused by correlated features, forward selection and aspect consolidation were implemented. Some black-box models outperformed DTs and LR. The forward-selected features correspond to brain areas previously associated with AD. Shapley values identified biologically plausible associations with moderate-to-strong correlations with feature importances. The most important RF features to predict AD conversion were the volume of the amygdalae and a cognitive test score. Good cognitive test performances and large brain volumes decreased the AD risk. The models trained using cognitive test scores significantly outperformed brain volumetric models ( $$p<0.05$$ p < 0.05 ). Cognitive Normal (CN) vs. AD models were successfully transferred to external datasets. In comparison to previous work, improved performances for ADNI and AIBL were achieved for CN vs. Mild Cognitive Impairment (MCI) classification using brain volumes. The Shapley values and the feature importances showed moderate-to-strong correlations.


  • Open Access

    Data analysis with Shapley values for automatic subject selection in Alzheimer’s disease data sets using interpretable machine learning

    by Louise Bloch, Christoph M. Friedrich, For The Alzheimer’s Disease Neuroimaging Initiative

    Background: For the recruitment and monitoring of subjects for therapy studies, it is important to predict whether mild cognitive impaired (MCI) subjects will prospectively develop Alzheimer’s disease (AD). Machine learning (ML) is suitable to improve early AD prediction. The etiology of AD is heterogeneous, which leads to high variability in disease patterns. Further variability originates from multicentric study designs, varying acquisition protocols, and errors in the preprocessing of magnetic resonance imaging (MRI) scans. The high variability makes the differentiation between signal and noise difficult and may lead to overfitting. This article examines whether an automatic and fair data valuation method based on Shapley values can identify the most informative subjects to improve ML classification. Methods: An ML workflow was developed and trained for a subset of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. The validation was executed for an independent ADNI test set and for the Australian Imaging, Biomarker and Lifestyle Flagship Study of Ageing (AIBL) cohort. The workflow included volumetric MRI feature extraction, feature selection, sample selection using Data Shapley, random forest (RF), and eXtreme Gradient Boosting (XGBoost) for model training as well as Kernel SHapley Additive exPlanations (SHAP) values for model interpretation. Results: The RF models, which excluded 134 of the 467 training subjects based on their RF Data Shapley values, outperformed the base models that reached a mean accuracy of 62.64% by 5.76% (3.61 percentage points) for the independent ADNI test set. The XGBoost base models reached a mean accuracy of 60.00% for the AIBL data set. The exclusion of those 133 subjects with the smallest RF Data Shapley values could improve the classification accuracy by 2.98% (1.79 percentage points). The cutoff values were calculated using an independent validation set. Conclusion: The Data Shapley method was able to improve the mean accuracies for the test sets. The most informative subjects were associated with the number of ApolipoproteinE ε4 (ApoE ε4) alleles, cognitive test results, and volumetric MRI measurements.